1# Library to Find Best eBook for Read
Author :
Release : 2008
Genre :
Kind : eBook
Book Rating : /5 ( reviews)
Book Synopsis Real world drug discovery : a chemist's guide to biotech and pharmaceutical research by :
Download or read book Real world drug discovery : a chemist's guide to biotech and pharmaceutical research written by . This book was released on 2008. Available in PDF, EPUB and Kindle. Book excerpt:
Author : Robert M. Rydzewski
Release : 2020-01-01
Genre : Science
Kind : eBook
Book Rating : 850/5 ( reviews)
Book Synopsis Real World Drug Discovery by : Robert M. Rydzewski
Download or read book Real World Drug Discovery written by Robert M. Rydzewski. This book was released on 2020-01-01. Available in PDF, EPUB and Kindle. Book excerpt: Real World Drug Discovery
Author : Elsevier Science & Technology Books
Release : 2016
Genre :
Kind : eBook
Book Rating : 160/5 ( reviews)
Book Synopsis Real World Drug Discovery: a Guide to Biotech and Pharmaceutical Research by : Elsevier Science & Technology Books
Download or read book Real World Drug Discovery: a Guide to Biotech and Pharmaceutical Research written by Elsevier Science & Technology Books. This book was released on 2016. Available in PDF, EPUB and Kindle. Book excerpt:
Author : National Academies of Sciences, Engineering, and Medicine
Release : 2019-04-05
Genre : Medical
Kind : eBook
Book Rating : 32X/5 ( reviews)
Book Synopsis Examining the Impact of Real-World Evidence on Medical Product Development by : National Academies of Sciences, Engineering, and Medicine
Download or read book Examining the Impact of Real-World Evidence on Medical Product Development written by National Academies of Sciences, Engineering, and Medicine. This book was released on 2019-04-05. Available in PDF, EPUB and Kindle. Book excerpt: Randomized controlled trials (RCTs) have traditionally served as the gold standard for generating evidence about medical interventions. However, RCTs have inherent limitations and may not reflect the use of medical products in the real world. Additionally, RCTs are expensive, time consuming, and cannot answer all questions about a product or intervention. Evidence generated from real-world use, such as real-world evidence (RWE) may provide valuable information, alongside RCTs, to inform medical product decision making. To explore the potential for using RWE in medical product decision making, the National Academies of Sciences, Engineering, and Medicine planned a three-part workshop series. The series was designed to examine the current system of evidence generation and its limitations, to identify when and why RWE may be an appropriate type of evidence on which to base decisions, to learn from successful initiatives that have incorporated RWE, and to describe barriers that prevent RWE from being used to its full potential. This publication summarizes the discussions from the entire workshop series.
Author : National Academies of Sciences, Engineering, and Medicine
Release : 2017-07-05
Genre : Medical
Kind : eBook
Book Rating : 650/5 ( reviews)
Book Synopsis Real-World Evidence Generation and Evaluation of Therapeutics by : National Academies of Sciences, Engineering, and Medicine
Download or read book Real-World Evidence Generation and Evaluation of Therapeutics written by National Academies of Sciences, Engineering, and Medicine. This book was released on 2017-07-05. Available in PDF, EPUB and Kindle. Book excerpt: The volume and complexity of information about individual patients is greatly increasing with use of electronic records and personal devices. Potential effects on medical product development in the context of this wealth of real-world data could be numerous and varied, ranging from the ability to determine both large-scale and patient-specific effects of treatments to the ability to assess how therapeutics affect patients' lives through measurement of lifestyle changes. In October 2016, the National Academies of Sciences, Engineering, and Medicine held a workshop to facilitate dialogue among stakeholders about the opportunities and challenges for incorporating real-world evidence into all stages in the process for the generation and evaluation of therapeutics. Participants explored unmet stakeholder needs and opportunities to generate new kinds of evidence that meet those needs. This publication summarizes the presentations and discussions from the workshop.
